• Home
  • About Us
  • Our People
  • Pipeline
  • News
  • Contact Us
Home
  • Home
  • About Us
  • Our People
  • Pipeline
  • News
  • Contact Us

Archives

Monthly Archive for: "December, 2017"
Home /
0
By FDM Digital
In Company News
Posted 4th December 2017

Say Hello to the Top 14 Female Entrepreneurs in European Biotech

READ MORE
 0
By FDM Digital
In Company News
Posted 4th December 2017

Mary Kerr CEO NeRRe Therapeutics guest speaker at a recent Labiotech meeting in London

Mary Kerr CEO NeRRe Therapeutics guest speaker at a recent Labiotech meeting in London

READ MORE

NeRRe Logo

NeRRe Therapeutics is a UK based clinical-stage company developing a unique portfolio of neurokinin (NK) receptor antagonists for the treatment of common debilitating conditions caused by neuronal hypersensitivity.

Useful Links
  • Contact Us
  • About Us
  • Privacy Policy
  • Cookie Notice
  • Terms & Conditions
  • Clinical Trials Privacy Notice
© 2018 NeRRe Therapeutics. All rights reserved. Website design by FDM Digital
Contact Us

Please fill out the form to get in touch with us.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Cookie Policy

More information about our Cookie Policy